Mechanism of action
Simethicone is an inert, surface-active agent composed of polydimethylsiloxane and silica gel. It functions as a defoaming agent that alters the elasticity of mucus-embedded gas bubbles in the gastrointestinal tract.
By reducing surface tension, simethicone allows smaller gas bubbles to coalesce into larger bubbles that are more easily expelled via belching or flatulence. It does not prevent gas formation or reduce the volume of gas present; rather, it facilitates the physical movement and elimination of existing gas.
Simethicone acts exclusively within the GI lumen and is not absorbed into the systemic circulation. It is pharmacologically and physiologically inert, exerting purely physical effects without any enzymatic, receptor-mediated, or metabolic activity.
- Simethicone is not absorbed systemically; it acts only in the GI lumen.
- Mechanism: reduces surface tension of gas bubbles, allowing coalescence and elimination.
- No clinically significant adverse effects or drug interactions.
- Safe in pregnancy, lactation, and all ages including neonates.
- Does not prevent gas formation; only facilitates removal of existing gas.
- No dose adjustment needed in renal or hepatic impairment.
- Often used as adjunct in endoscopy to reduce gas artifacts.
- Evidence for efficacy in infant colic is weak and inconsistent.
Indications
Approved indications:
- Relief of symptoms associated with excess gas in the digestive tract, including bloating, pressure, fullness, and discomfort
- Flatulence and functional gastric distention
- Postoperative gaseous distention and gas pain
Off-label and diagnostic uses:
- Adjunct in gastrointestinal endoscopy and radiography to reduce gas artifacts and improve visualization
- Symptomatic relief in conditions with secondary gas accumulation, such as irritable bowel syndrome, functional dyspepsia, and post-surgical ileus
- Infant colic (evidence for efficacy is limited and controversial)
Simethicone is available over-the-counter and is often combined with antacids, proton pump inhibitors, or other gastrointestinal agents.
Pharmacokinetics
Absorption: Simethicone is not absorbed from the gastrointestinal tract. It remains in the GI lumen and acts locally.
Distribution: No systemic distribution occurs because the drug is not absorbed.
Metabolism: Simethicone is chemically inert and is not metabolized by the body.
Excretion: It is eliminated unchanged in the feces. The onset of action is rapid, typically within minutes, as it begins to act immediately upon contact with gas bubbles in the stomach and intestines.
Because simethicone has no systemic pharmacokinetics, it has no drug-drug interactions mediated by cytochrome P450 enzymes or renal or hepatic clearance pathways.
Adverse effects
Simethicone is extremely well tolerated because it is not absorbed and has no systemic effects.
Common adverse effects:
- Adverse effects are exceedingly rare
- Mild gastrointestinal symptoms such as nausea or mild diarrhea have been reported anecdotally but are not clearly attributable to the drug
Serious adverse effects:
- No serious adverse effects have been documented in clinical use
- Allergic reactions are theoretically possible but extraordinarily rare
Special populations:
- No dose adjustment is needed in renal or hepatic impairment
- Safe in pregnancy and lactation due to lack of absorption
Contraindications and warnings
Absolute contraindications:
- Known hypersensitivity to simethicone or any component of the formulation (extremely rare)
Warnings and precautions:
- Simethicone treats symptoms of gas but does not address underlying pathology; persistent or severe abdominal symptoms should be evaluated for serious conditions such as bowel obstruction, perforation, or other acute abdominal emergencies
- Not effective for pain or discomfort due to causes other than gas accumulation
Pregnancy and lactation:
- Pregnancy: Considered safe; no systemic absorption means no fetal exposure. Frequently used during pregnancy without reported adverse outcomes
- Lactation: Safe; not excreted in breast milk due to lack of absorption
Pediatric use:
- Widely used in infants and children; however, evidence for efficacy in infant colic remains inconclusive
Drug interactions
Simethicone has virtually no clinically significant drug interactions because it is not absorbed and does not affect the absorption, metabolism, or excretion of other drugs.
Theoretical considerations:
- As a surface-active agent, simethicone could theoretically alter the dissolution or absorption kinetics of other orally administered drugs, but this has not been demonstrated clinically
- When combined with antacids or other GI agents in fixed-dose formulations, interactions are related to those co-administered agents, not to simethicone itself
Diagnostic interference:
- May improve the quality of endoscopic and radiographic imaging by reducing gas bubbles, which is often a desired effect in these procedures
Clinical pearls
- Simethicone is one of the safest drugs in clinical use; it has no systemic absorption, metabolism, or excretion, making it suitable for all patient populations including neonates, pregnant women, and those with organ dysfunction.
- It does not reduce the production of gas; it only facilitates the elimination of gas already present in the GI tract. Patients should be counseled that it treats symptoms, not the underlying cause of gas.
- Commonly combined with antacids in over-the-counter products; the simethicone component does not contribute to acid neutralization but helps relieve bloating that often accompanies dyspepsia.
- Useful as a pre-procedural agent before upper endoscopy or barium studies to reduce foam and gas artifacts, improving mucosal visualization.
- Despite widespread use for infant colic, multiple systematic reviews and meta-analyses have failed to demonstrate consistent benefit over placebo in this indication.
- Because it is inert and not absorbed, simethicone can be taken as needed without concerns for tolerance, dependence, or long-term toxicity.
- Onset of symptom relief is rapid, often within minutes, making it suitable for acute symptomatic management.
- Not a substrate, inhibitor, or inducer of any cytochrome P450 enzyme, and has no effect on renal or hepatic drug clearance pathways.
Practice questions
1. A 34-year-old woman at 28 weeks gestation presents with severe bloating and abdominal discomfort. She describes feeling 'full of gas' after meals. Physical examination reveals a gravid uterus and mild abdominal distention with tympany, but no tenderness or organomegaly. Bowel sounds are normal. She asks for medication to relieve her symptoms. Which of the following medications is most appropriate?
2. A 3-week-old infant is brought to the pediatrician for inconsolable crying episodes lasting 2-3 hours each evening. The infant draws his legs up during episodes and appears to be in discomfort. He is breastfed, gaining weight appropriately, and has normal bowel movements. Physical examination is unremarkable. The parents ask about simethicone drops they saw advertised for infant colic. What is the most accurate statement regarding simethicone use in this infant?
3. A 58-year-old man with chronic kidney disease stage 4 (eGFR 22 mL/min/1.73m²) and cirrhosis presents with bloating and abdominal fullness after meals. He takes multiple medications including furosemide, spironolactone, lactulose, and rifaximin. He requests something to help with his gas symptoms. Which characteristic of simethicone makes it particularly suitable for this patient?
Frequently asked questions
How does simethicone work?
Simethicone works by reducing the surface tension of gas bubbles in the gastrointestinal tract, allowing small bubbles to merge into larger ones that can be more easily expelled through belching or flatulence. It is a surface-active agent that acts physically, not pharmacologically, and remains entirely within the GI lumen without being absorbed into the bloodstream. This mechanism provides rapid symptomatic relief from bloating and gas discomfort.
What are the side effects of simethicone?
Simethicone has essentially no side effects because it is not absorbed into the body and acts only locally in the gastrointestinal tract. Adverse reactions are exceedingly rare, and no serious side effects have been documented in clinical use. It is considered one of the safest medications available and can be used by virtually all patient populations, including infants, pregnant women, and individuals with organ dysfunction.
Is simethicone safe during pregnancy?
Yes, simethicone is considered safe during pregnancy. Because it is not absorbed from the gastrointestinal tract, there is no systemic exposure and therefore no fetal exposure to the drug. It has been used extensively in pregnant women without any reported adverse outcomes. Simethicone is a preferred option for managing bloating and gas discomfort during pregnancy when non-pharmacologic measures are insufficient.
Can simethicone be given to infants?
Simethicone is commonly given to infants, particularly for the treatment of colic and gas discomfort, and is considered safe due to its lack of systemic absorption. However, clinical evidence for its effectiveness in treating infant colic is weak and inconsistent, with multiple studies showing no significant benefit over placebo. Despite limited efficacy data, it remains widely used because of its excellent safety profile and lack of harm.
Simethicone vs antigas — what is the difference?
Simethicone is the generic name for the active pharmaceutical ingredient, while 'antigas' is a general term used to describe products that relieve gas symptoms. Most over-the-counter antigas products contain simethicone as the active ingredient, sometimes alone or combined with antacids or other agents. The terms are often used interchangeably in consumer products, but simethicone specifically refers to the chemical compound that reduces gas bubble surface tension.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A03AX13
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.